SU CASE Center Company Receives Prestigious Grant From National Institutes Of Health To Develop Biological Probes To Aid In Disease Diagnosis, Treatment
October 31, 2008
October 31, 2008
SYRACUSE, N.Y., Oct. 31 -- Syracuse University issued the following press release:
OrthoSystems Inc., a biotechnology start-up company founded by Syracuse University researchers, has been awarded a $977,000 Phase II grant from the Small Business Innovation Research (SBIR) program of the National Institutes of Health to further develop and commercialize the company's core technology-a novel technique to aid in the discovery of biological probes that can be used in the diagnosis and . . .
OrthoSystems Inc., a biotechnology start-up company founded by Syracuse University researchers, has been awarded a $977,000 Phase II grant from the Small Business Innovation Research (SBIR) program of the National Institutes of Health to further develop and commercialize the company's core technology-a novel technique to aid in the discovery of biological probes that can be used in the diagnosis and . . .